151 related articles for article (PubMed ID: 28408852)
1. The role of the chemokine receptor XCR1 in breast cancer cells.
Yang XL; Qi LG; Lin FJ; Ou ZL
Breast Cancer (Dove Med Press); 2017; 9():227-236. PubMed ID: 28408852
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
Do HTT; Cho J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analyses of chemokines reveal that down-regulation of XCR1 is associated with advanced hepatocellular carcinoma.
Yanru W; Zhenyu B; Zhengchuan N; Qi Q; Chunmin L; Weiqiang Y
Biochem Biophys Res Commun; 2018 Feb; 496(4):1314-1321. PubMed ID: 29408492
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Fibulin-2 expression with proliferation, migration and invasion of breast cancer cells.
Zhang X; Duan L; Zhang Y; Zhao H; Yang X; Zhang C
Oncol Lett; 2020 Aug; 20(2):1945-1951. PubMed ID: 32724439
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Chemokine receptor CXCR6 and its significance in breast cancer cell lines].
Cheng H; Chen NY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):405-9. PubMed ID: 24941806
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
9. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
10. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
11. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
[TBL] [Abstract][Full Text] [Related]
12. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ANXA3 expression by RNA interference inhibits the proliferation and invasion of breast cancer cells.
Zhou T; Li Y; Yang L; Liu L; Ju Y; Li C
Oncol Rep; 2017 Jan; 37(1):388-398. PubMed ID: 27878264
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
15. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
16. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Yang XL; Liu KY; Lin FJ; Shi HM; Ou ZL
Oncol Rep; 2017 Sep; 38(3):1393-1401. PubMed ID: 28713975
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway.
Ke K; Lou T
Oncol Lett; 2017 Nov; 14(5):5994-6000. PubMed ID: 29113237
[TBL] [Abstract][Full Text] [Related]
18. [Expression of non-secretory CXCL16 and its impact on biological characteristics in breast cancer cell lines].
Fang YY; Lei QQ; Li Y; Chen NY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):522-5, 530. PubMed ID: 24059100
[TBL] [Abstract][Full Text] [Related]
19. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
[TBL] [Abstract][Full Text] [Related]
20. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]